BRAF alterations are associated with complex mutational profiles in malignant melanoma
Maria Daniotti, Maria Oggionni, Tiziana Ranzani et al. · Oncogene · 2004
Cited by 210 works. doi:10.1038/sj.onc.1207780
Authors
- Maria Daniotti
- Maria Oggionni
- Tiziana Ranzani
- Viviana Vallacchi
- Valentina Campi
- Delia Di Stasi
- Gabriella Della Torre
- Federica Perrone
- Chiara Luoni
- Simona Suardi
- Milo Frattini
- Silvana Pilotti
- Andrea Anichini
- Gabrina Tragni
- Giorgio Parmiani
- Marco Alessandro Pierotti
- Monica Rodolfo
References
- A simple salting out procedure for extracting DNA from human nucleated cells
- Mutations of the BRAF gene in human cancer
- High frequency of BRAF mutations in nevi
- A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
- The p16INK4a/CDKN2A tumor suppressor and its relatives
- Mutations in Human ARF Exon 2 Disrupt Its Nucleolar Localization and Impair Its Ability to Block Nuclear Export of MDM2 and p53
- Genetic Interaction Between NRAS and BRAF Mutations and PTEN/MMAC1 Inactivation in Melanoma
- Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.
- Epigenetic PTEN Silencing in Malignant Melanomas without PTEN Mutation
- Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial